19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2525



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace


powered by centersite dot net
Alzheimers Disease and other Cognitive Disorders
Resources
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Health Tip: Make Your Home Safer For People With Alzheimer'sAs Hearing Fades With Age, Dementia Risk May RiseAlzheimer's Cases to Double by 2060: ReportGene Discovery May Help Fight Alzheimer'sMemory Scores Limited As Alzheimer's Screening ToolMagnesium Boosts Environmental Enrichment in Alzheimer'sCould New 'Brain Training' Program Help Prevent Dementia?Millions Could Miss Out on a Potential Alzheimer's BreakthroughSleep Apnea May Boost Alzheimer's RiskNew Finding Hints at Clue to DementiaResilient Brain Connections May Help Against Alzheimer'sAmerica's Dementia Caregivers Cite Stresses, RewardsHealth Tip: Identifying Vascular DementiaOne Type of Dementia Is Especially CostlyA More Accurate Predictor for Alzheimer's?Failing Sense of Smell Tied to Dementia RiskMagnesium Levels Tied to Dementia RiskIs Dementia Declining Among Older Americans?Intracranial Pressure Monitoring No Benefit in Pediatric TBIGender-Specific High-Risk 'Window' Seen in Alzheimer'sWomen at Risk for Alzheimer's Face Critical 10-Year Window, Study SaysDo Fewer Nightly Dreams Mean Higher Dementia Risk in Seniors?Dementia Care: A Huge Financial Burden for U.S. FamiliesPopular Heartburn Drugs Don't Raise Risk of Alzheimer's: StudyFamilies Shoulder Majority of Costs Related to Dementia CareMidlife Vascular Risk Factors Tied to Increased Risk of DementiaBlood Pressure Fluctuations Tied to Dementia Risk in StudyMidlife Behaviors May Affect Your Dementia RiskTraveling With Dementia: Tips for Family CaregiversHigher Risk of Dementia Seen in Those Hailing From 'Stroke Belt'Health Tip: Alzheimer's Affects SleepIncreased Dementia Risk With Hearing Loss in Older AdultsNoninvasive Brain Test May Pinpoint Type of DementiaTargeting 9 Risk Factors Could Prevent 1 in 3 Dementia Cases: StudyAAIC: Rx + Training Shows Benefit in Advanced Alzheimer'sAAIC: Alzheimer Biomarkers Up With Sleep Disordered BreathingDozens of Potential Alzheimer's Meds in the PipelineSpecial Training Plus Medication Might Help People With Advanced Alzheimer'sOne Social Hour a Week Can Help Someone With DementiaSleep Problems: An Early Warning Sign of Alzheimer's?Severe Head Injury May Raise Dementia Risk Years LaterPPIs Not Found to Raise Risk of Alzheimer's DiseasePopular Heartburn Meds Don't Raise Alzheimer's Risk: StudyLifestyle Changes Might Prevent or Slow DementiaSevere Headaches Plague Vets With Traumatic Brain InjuriesSticky Brain 'Plaques' Implicated in Alzheimer's Again'Making the Best of It': Families Face the Heavy Burden of Alzheimer'sCognitive Decline Linked to Visual Field VariabilityAlzheimer's Deaths Jump 55 Percent: CDCLife Expectancy Slighter Shorter With Parkinson's, Dementia
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

Continuing Warfarin Protective After Diagnosis of Dementia


HealthDay News
Updated: Jan 6th 2017

new article illustration

FRIDAY, Jan. 6, 2017 (HealthDay News) -- For veterans receiving warfarin for nonvalvular atrial fibrillation, continuing warfarin after a diagnosis of dementia is associated with a protective effect in prevention of stroke and mortality, according to a study published online Dec. 30 in the Journal of the American Geriatrics Society.

Ariela R. Orkaby, M.D., from the Veterans Affairs Boston Healthcare System, and colleagues conducted a retrospective cohort study involving 2,572 veterans aged 65 years and older who had been receiving warfarin for nonvalvular atrial fibrillation for six months or more and were newly diagnosed with dementia. Participants were followed for up to four years.

The researchers found that 405 individuals (16 percent) persisted on warfarin therapy after a diagnosis of dementia. Warfarin had a significant protective effect in prevention of ischemic stroke, major bleeding, and all-cause mortality (hazard ratios [HRs], 0.64 [95 percent confidence interval (CI), 0.46 to 0.89; P = 0.008], 0.72 [95 percent CI, 0.55 to 0.94; P = 0.02], and 0.66 [95 percent CI, 0.55 to 0.79; P < 0.001], respectively). The protective effect of continuing warfarin persisted in prevention of stroke and mortality in propensity-matched analyses (HRs, 0.74 [95 percent CI, 0.54 to 0.996; P = 0.047] and 0.72 [95 percent CI, 0.60 to 0.87; P < 0.001], respectively); there was no statistically significant decrease in the risk of major bleeding (HR, 0.78 [95 percent CI, 0.61 to 1.01; P = 0.06]).

"Discontinuing warfarin after a diagnosis of dementia is associated with a significant increase in stroke and mortality," the authors write.

Full Text (subscription or payment may be required)